Organigram Expands Edison Cannabis Co. Dried Flower Portfolio with Two New High THC Strains: GMO Cookies and MAC-1
April 22 2021 - 1:30PM
Business Wire
As part of the continued expansion of its Edison Cannabis Co.
(“Edison”) line of products, Organigram Holdings Inc.
(“Organigram” or the “Company”) (TSX: OGI) (NASDAQ:
OGI), the parent company of Organigram Inc., a leading producer of
cannabis, is pleased to announce the launch of two new Edison dried
flower strains including the potent GMO Cookies and legendary
citrus diesel MAC-1.
Both strains feature a distinct phenotypic profile, flavour and
aroma as a result of being grown in one of Organigram’s strain
specific micro-climates.
“Organigram grows and catalogues over fifty new plant genetics
every year; GMO Cookies and MAC-1 are excellent examples of diverse
and high-quality genetics that we will continue to introduce to the
Edison portfolio,” says Greg Engel, CEO, Organigram. “At
Organigram, our goal is to continue curating a fresh lineup of
potent strains that deliver on value, aroma, and flavour for
Edison-savvy, adult consumers.”
GMO Cookies:
An indica strain with a THC range of 20-26%, GMO Cookies’
potency is matched only by the strength of its aroma: sharp and
musty with notes of garlic and mushroom. Its crown-shaped flowers
are dark green with purple flecks, bright orange pistils and heavy
trichomes. The strain’s dominant terpenes include Limonene,
Caryophyllene, Humulene, and Myrcene.
Available in 3.5g format or a package of three x 0.5g pre-rolls,
GMO Cookies is grown in a custom micro-climate environment
optimized for this cultivar and is packaged with a dual-boost
humidity pack to preserve freshness.
MAC-1:
A legendary hybrid strain, MAC-1 features an upfront citrus
flavour, with a mid-range diesel smell and finishes with notes of
spice. The flowers are dense and visually striking, composed of
light and dark greens, a punch of light purple, fiery copper
pistils and a thick layer of frosty trichomes. The strain’s
dominant terpenes include Limonene, Caryophyllene, α-Pinene,
β-Pinene, Linalool and a THC range of 20-26%.
MAC-1 is available in 3.5g format or in a package of three x
0.5g pre-rolls. Grown in strain-specific environments customized to
MAC-1 help the plant retain its true-to-flower terpene aroma
profiles and consistent potency levels.
GMO Cookies and MAC-1 will be available soon at select retailers
across the country.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and a
Toronto Stock Exchange listed company whose wholly owned
subsidiaries include Organigram Inc., a licensed producer of
cannabis and cannabis-derived products in Canada and The Edibles
and Infusions Corporation, a cannabis infused soft chew and
confectionary manufacturer in Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company's global footprint. Organigram has also developed a
portfolio of adult use recreational cannabis brands including The
Edison Cannabis Company, Indi, Bag o’ Buds, SHRED and Trailblazer.
Organigram's primary facility is located in Moncton, New Brunswick
with another leased manufacturing facility in Winnipeg, Manitoba.
The Company is regulated by Health Canada under the Cannabis Act
(Canada) and the Cannabis Regulations (Canada).
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
factors and risks as disclosed in the Company’s most recent annual
information form, management’s discussion and analysis and other
Company documents filed from time to time on SEDAR (see
www.sedar.com) and filed or furnished to the Securities and
Exchange Commission on EDGAR (see www.sec.gov). Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release.
Although the Company believes that the assumptions and factors used
in preparing the forward-looking information in this news release
are reasonable, undue reliance should not be placed on such
information and no assurance can be given that such events will
occur in the disclosed time frames or at all. The forward-looking
information included in this news release are made as of the date
of this news release and the Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking information, whether as a result of new
information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210422005744/en/
For Investor Relations enquiries: Amy Schwalm Vice
President, Investor Relations Amy.Schwalm@organigram.ca (416)
704-9057
For Media enquiries: Marlo Taylor
mtaylor@gagecommunications.ca
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Apr 2023 to Apr 2024